Click Therapeutics, Inc
- Home
- Companies
- Click Therapeutics, Inc
- Products
- Clickheart - Model CT-111 - Acute ...
Clickheart - Model CT-111 -Acute Coronary Syndrome
Clickheart is under development as a clinically-validated digital program for acute coronary syndrome.
Most popular related searches
coronary syndromes
coronary syndrome
class II medical device
clinical validation
patient engagement
cardiac event
medical device
clinical program
medication adherence
medical adherence
- Outpatient Navigator
- Medication Access & Adherence
- Physical Activity
- Diet Optimization
- Risk Factor Optimization
- Social Engagement
Clickheart combines multiple clinically-validated mechanisms of action with Click’s adaptive patient engagement platform and is designed to reduce LDL and risk of major adverse cardiac events (MACE) in patients with acute coronary syndrome (ACS). Click is seeking FDA clearance for Clickheart as a Class II medical device for the reduction of LDL in recently hospitalized ACS patients.